Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-04-002027
Filing Date
2004-05-19
Accepted
2004-05-19 17:42:33
Documents
2
Period of Report
2004-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 23358
2 POWER OF ATTORNEY d59749_exhibit.htm EX-99 8565
  Complete submission text file 0001005477-04-002027.txt   33985
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O MEMORIAL SLOAN KETTERING 1275 YORK AVE. NEW YORK NY 10021
GOLDE DAVID (Reporting) CIK: 0001058148 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 04819587